Biohaven Pharma (BHVN), Royalty Pharma (RPRX) Announce Funding Agreement Totaling up to $450 Million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Biohaven Pharma (BHVN), Royalty Pharma (RPRX) Announce Funding Agreement Totaling up to $450 Million

Biohaven Pharma (BHVN) Tops Q2 EPS by 6c, Revenues Beat

August 10, 2020 7:47 AM EDT

Biohaven Pharma (NYSE: BHVN) reported Q2 EPS of ($2.55), $0.06 better than the analyst estimate of ($2.61). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.65 million.

Vlad Coric, M.D. Chief Executive Officer, commented, "This has been an... More